The Potential of Secondary Metabolites from Plants as Drugs or Leads against Protozoan Neglected Diseases-Part III: In-Silico Molecular Docking Investigations.

William N Setzer, Ifedayo Victor Ogungbe

Journal: Molecules (Basel, Switzerland) 2017;21(10):1389

PMID: 27775577

Abstract

Malaria, leishmaniasis, Chagas disease, and human African trypanosomiasis continue to cause considerable suffering and death in developing countries. Current treatment options for these parasitic protozoal diseases generally have severe side effects, may be ineffective or unavailable, and resistance is emerging. There is a constant need to discover new chemotherapeutic agents for these parasitic infections, and natural products continue to serve as a potential source. This review presents molecular docking studies of potential phytochemicals that target key protein targets in spp., spp., and spp.

Address: Department of Chemistry and Biochemistry, Jackson State University, Jackson, MS 39217, USA. [email protected].; Department of Chemistry, University of Alabama in Huntsville, Huntsville, AL 35899, USA. [email protected].

DOI: 10.3390/molecules21101389

Link outs

Free resources

Full Text Sources:

Other Literature Sources:

https://scite.ai/reports/27775577

Miscellaneous:

https://assays.cancer.gov/CPTAC-1612

MeSH Terms: Antiprotozoal Agents, Biological Products, Computer Simulation, Drug Discovery, Humans, Models, Molecular, Molecular Docking Simulation, Molecular Structure, Neglected Diseases, Phytotherapy, Protozoan Infections, Protozoan Proteins, Structure-Activity Relationship